Home › Funds › SAMLYN CAPITAL, LLC › INSM

SAMLYN CAPITAL, LLC position in INSM

INSMED INC · Health Care

SAMLYN CAPITAL, LLC reported holding 732,568 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$78.1M, representing 1.29% of its reported portfolio and ranking #24 among its reported holdings. SAMLYN CAPITAL, LLC has disclosed INSM holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)732.57K sh
Reported value held$78.11M
Portfolio Weight1.29%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SAMLYN CAPITAL, LLC's INSM position evolved

SAMLYN CAPITAL, LLC first disclosed a stake in INSM in Q3 2023 at 1,381,057 shares (US$34.9M). The position peaked in Q2 2026 at 732,568 shares, worth US$78.1M. Across 10 filings, SAMLYN CAPITAL, LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 732,568 shares valued at US$78.1M — an increase of 315,363 shares quarter over quarter.. Notable position changes include a 54% trim in Q1 2024 (shares rose 147% over the following quarter), a 41% trim in Q3 2024 (shares fell 5% over the following quarter), a 76% increase in Q2 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.38M $34.87M New
Q4 2023 1.29M $39.88M Reduce
Q1 2024 587.63K $15.94M Reduce
Q2 2024 359.25K $24.07M Reduce
Q3 2024 211.50K $15.44M Reduce
Q4 2024 159.06K $10.98M Reduce
Q3 2025 292.64K $42.14M New
Q4 2025 369.57K $64.32M Add
Q1 2026 417.20K $68.22M Add
Q2 2026 732.57K $78.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INSM and 13F data

INSM (INSMED INC) is a Health Care company. 40 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INSM

All INSM fund holders →

FAQ

How long has SAMLYN CAPITAL, LLC held INSM?

SAMLYN CAPITAL, LLC has disclosed INSM holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

What is SAMLYN CAPITAL, LLC's current position in INSM?

As of Q2 2026, SAMLYN CAPITAL, LLC holds 732.57K shares of INSM (INSMED INC), valued at $78.11M, representing 1.29% of its reported portfolio and ranking #24.

Has SAMLYN CAPITAL, LLC been buying or selling INSM?

In the latest 13F filing (Q2 2026), SAMLYN CAPITAL, LLC increased its position in INSM. The position peaked in Q2 2026 at 732.57K shares.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.